Genetic predisposition to hypertension sensitizes borderline hypertensive rats to the hypertensive effects of prenatal glucocorticoid exposure

Journal of Physiology

Volumn 586, Issue 2, 2008, Pages 673-684

  Bechtold, Andrea G ^a   Vernon, Kathy ^b   Hines, Tina ^c   Scheuer, Deborah A ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; INSULIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BORDERLINE HYPERTENSION; BORDERLINE HYPERTENSIVE RAT; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; GENETIC PREDISPOSITION; HEART RATE; INDWELLING CATHETER; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; RAT; SEX DIFFERENCE; STRESS; ACUTE STRESS; ADULT; ARTERY CATHETERIZATION; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; DISEASE PREDISPOSITION; DRUG MEGADOSE; GESTATION PERIOD; HEREDITY; HYPERTENSION; IMMOBILIZATION STRESS; WISTAR KYOTO RAT;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CORTICOSTERONE; DEXAMETHASONE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HEART RATE; HYPERTENSION; INSULIN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RISK FACTORS; STRESS;

EID: 38149078853     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.141580     Document Type: Article

References (57)

1. Alexander BT (2006). Fetal programming of hypertension. Am J Physiol Regul Comp Physiol 290, 1-10.
2. Armitage JA, Khan IY, Taylor PD, Nathanielsz PW & Poston L (2004). Developmental programming of the metabolic syndrome by maternal nutritional imbalance: How strong is the evidence from experimental models in mammals? J Physiol 561, 355-357.
3. Barker DJ (2000). In utero programming of cardiovascular disease. Theriogenology 53, 555-574.
4. Barker DJP (2003). Coronary heart disease: A disorder of growth. Horm Res 59, 35-41.
5. Benediktsson R, Lindsay RS, Noble J, Seckl JR & Edwards CRW (1993). Glucocorticoid exposure in utero: A new model for adult hypertension. Lancet 341, 339-341.
6. Bertram CE & Hanson MA (2001). Animal models and programming of metabolic syndrome. Br Med Bull 60, 103-121.
7. Celsi G, Kistner A, Aizman R, Eklof A-C, Ceccatelli S, Santiago AD & Jacobson SH (1998). Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring. Pediatr Res 44, 317-322.
8. Clark PM (1998). Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Eur J Pediatr 157, S7-S10.
9. Cleasby ME, Kelly PAT, Walker BR & Seckl JR (2003). Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids. Endocrinology 144, 999-1007.
10. + exchanger by dexamethasone. Am J Physiol Regul Comp Physiol 292, R1230-R1235.
11. Dodic M, Moritz K, Koukoulas I & Wintour EM (2002). Programmed hypertension: Kidney, brain or both? Trends Endocrinol Metab 13, 403-408.
12. Doyle LW, Ford GW, Davis NM & Callanan C (2000). Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci 98, 137-142.
13. Eriksson J, Forsen T, Tuomilehto J, Osmond C & Barker DJ (2000). Fetal and childhood growth and hypertension in adult life. Hypertension 36, 790-794.
14. Fagerberg B, Bondjers L & Nilsson P (2004). Low birth weight in combination with catch-up growth predicts the occurrence of metabolic syndrome in men at late middle age: The atherosclerosis and insulin resistance study. J Intern Med 256, 254-259.
15. Forrester T (2004). A critical evaluation of the fetal origins hypothesis and its implications for developing countries. J Nutr 134, 211-216.
16. Fowden AL, Giussani DA & Forhead AJ (2006). Intrauterine programming of physiological systems: Causes and consequences. Physiology (Bethesda) 21, 29-37.
17. Fuchs LC, Hoque AM & Clarke NL (1998). Vascular and hemodynamic effects of behavioral stress in borderline hypertensive and Wistar-Kyoto rats. Am J Physiol Regul Comp Physiol 274, 375-382.
18. Gardner DS, Jackson AA & Langley-Evans SC (1998). The effect of prenatal diet and glucocorticoids on growth and systolic blood pressure in the rat. Proc Nutr Soc 57, 235-240.
19. Han S, Chen X, Cox B, Yang C-L, Wu Y-M, Naes L & Westfall T (1998). Role of neuropeptide Y in cold stress-induced hypertension. Peptides 19, 351-358.
20. Hardman JG, Limbird LE & Goodman Gilman A (eds) (2006). The Pharmacological Basis of Therapeutics. McGraw-Hill, New York.
21. Henriksen T & Clausen T (2002). The fetal origins hypothesis: placental insufficiency and inheritance versus maternal malnutrition in well-nourished populations. Acta Obstet Gynecol Scand 81, 112-114.
22. Hunt RA & Tucker DC (1993). Developmental sensitivity to high dietary sodium chloride in borderline hypertensive rats. Hypertension 22, 524-550.
23. Huxley RR, Shiell AW & Law CM (2000). The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: A systematic review of the literature. J Hypertens 18, 815-831.
24. Igosheva N, Klimova O, Anishchenko T & Glover V (2004). Prenatal stress alters cardiovascular responses in adult rats. J Physiol 557, 273-285.
25. Igosheva N, Taylor PD, Poston L & Glover V (2007). Prenatal stress in the rat results in increased blood pressure responsiveness to stress and enhanced arterial reactivity to neuropeptide Y in adulthood. J Physiol 582, 665-674.
26. Izzo JI & Black HR (eds) (2003). Hypertension Primer. Lippincott, Williams & Wilkens, Philadelphia.
27. Jones A, Beda A, Ward AMV, Osmond C, Phillips DIW, Moore VM & Simpson DM (2007). Size at birth and autonomic function during psychological stress. Hypertension 49, 548-555.
28. Kapoor A, Dunn E, Kostaki A, Andrews MH & Matthews SG (2006). Fetal programming of the hypothalamo-pituitary-adrenal function: Prenatal stress and glucocorticoids. J Physiol 572, 31-44.
29. Kurtz TW, Griffin KA, Bidani AK, Davisson RL & Hall JE (2005). Recommendations for blood pressure measurement in humans and experimental animals: Part 2: Blood pressure measurement in experimental animals: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council On High Blood Pressure Research. Arterioscler Thromb Vasc Biol 25, e22-e33.
30. Langdown ML, Smith ND, Sugden MC & Holness MJ (2001). Excessive glucocorticoid exposure during late intrauterine development modulates expression of cardiac uncouplng proteins in adult hypertensive male offspring. Pflugers Arch 442, 248-255.
31. Lawler JE, Cox RH, Sanders BJ & Mitchell VP (1988). The Borderline Hypertensive Rat: A model for studying the mechanisms of environmentally induced hypertension. Health Psychol 7, 137-147.
32. Levitt NS, Lindsay RS, Holmes MC & Seckl JR (1996). Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64, 412-418.
33. Louey S & Thornburg KL (2005). The prenatal environment and later cardiovascular disease. Early Hum Dev 81, 745-751.
34. McDonald TJ, Franco KL, Brown JM, Jenkins SL, Nathanielsz PW & Nijland MJ (2003). Betamethasone in the last week of pregnancy causes fetal growth retardation but not adult hypertension in rats. J Soc Gynecol Invest 10, 469-473.
35. Mansi JA & Drolet G (1997). Chronic stress induces sensitization in sympathoadrenal response to stress in borderline hypertensive rats. Am J Physiol Regul Integr Comp Physiol 272, R813-R820.
36. Mansi JA, Rivest S & Drolet G (1998). Effect of immobilization stress on transcriptional activity of inducible immediate-early genes, corticotropin-releasing factor, its type 1 receptor, and enkephalin in the hypothalamus of borderline hypertensive rats. J Neurochem 70, 1556-1566.
37. Martins JP, Monteiro JC & Paixao AD (2003). Renal function in adult rats subjected to prenatal dexamethasone. Clin Exper Pharm Physiol 30, 32-37.
38. + exchanger is associated with hyperinsulinemia in borderline hypertensive rats. Eur J Clin Invest 31, 193-200.
39. Moritz KM, Boon WM & Wintour EM (2005). Glucocorticoid programming of adult disease. Cell Tissue Res 322, 81-88.
40. Nathanielsz PW (2006). Animal models that elucidate basic principles of the developmental origins of adult diseases. ILAR J 47, 74-82.
41. O'Regan D, Kenyon CJ, Seckl JR & Holmes MC (2004). Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular physiology. Am J Physiol Endocrinol Metab 287, E863-E870.
42. Ortiz LA, Quan A, Weinberg A & Baum M (2001). Effect of prenatal dexamethasone on rat renal development. Kidney Int 59, 1663-1669.
43. Ortiz LA, Quan A, Zarzar F, Weinburg A & Baum M (2003). Prenatal dexamethasone programs hypertension and renal injury in the rat. Hypertension 41, 328-334.
44. Owen D, Andrews MH & Matthews SG (2005). Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci Biobehav Rev 29, 209-226.
45. Phillips DIW, Barker DJ, Fall CHD, Seckl JR, Whorwood CB, Wood PJ & Walker BR (1998). Elevated plasma cortisol concentrations: A link between low birth weight and the insulin resistance syndrome? J Clin Endorinol Metab 83, 757-760.
46. Sanders BJ & Lawler JE (1992). The borderline hypertensive rat (BHR) as a model for environmentally-induced hypertension: A review and update. Neurosci Biobehav Rev 16, 207-217.
47. Scheuer DA, Bechtold AG, Shank SS & Akana SF (2004). Glucocorticoids act in the dorsal hindbrain to increase arterial pressure. Am J Physiol Heart Circ Physiol 286, H458-H467.
48. Seckl JR & Meaney MJ (2004). Glucocorticoid programming. Ann N Y Acad Sci 1032, 63-84.
49. Singh RR, Cullen-McEwen LA, Kett MM, Boon WM, Dowling J, Bertram JF & Moritz KM (2007). Prenatal glucocorticoid exposure results in altered AT1/AT2, nephron deficit and hypertension in rat offspring. J Physiol 579, 503-513.
50. Sloboda DM, Challis JRG, Moss TJM & Newnham JP (2005). Synthetic glucocorticoids: Antenatal administration and long-term implications. Curr Pharm Des 11, 1459-1472.
51. Stocker CJ, Arch JRS & Cawthorne MA (2005). Fetal origins of insulin resistance and obesity. Proc Nutr Soc 64, 143-145.
52. Sugden MC, Langdown ML, Munns MJ & Holness MJ (2001). Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur J Endocrinol 145, 529-539.
53. Szitanyi P, Janda J & Poledne R (2003). Intrauterine undernutrition and programming as a new risk of cardiovascular disease in later life. Physiol Res 52, 389-395.
54. Tonkiss J, Trzcinska M, Galler JR, Ruiz-Opazo N & Herrera VLM (1998). Prenatal malnutrition-induced changes in blood pressure; dissociation of stress and nonstress responses using radiotelemetry. Hypertension 32, 108-114.
55. Ward AMV, Moore VM, Steptoe A, Cockington RA, Robinson JS & Phillips DIW (2003). Size at birth and cardiovascular responses to psychological stressors: Evidence for prenatal programming in women. J Hypertens 22, 2295-2301.
56. Woods LL (2006). Maternal glucocorticoids and prenatal programming of hypertension. Am J Physiol Regul Comp Physiol 291, R1069-R1075.
57. Woodworth CH, Knardahl S, Sanders BJ, Kirby RF & Johnson AK (1990). Dam strain affects cardiovascular reactivity to acute stress in BHR. Physiol Behav 47, 139-144.